Detalles de la búsqueda
1.
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.
Oncologist
; 29(2): 159-165, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37669224
2.
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.
Oncologist
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716772
3.
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.
Oncologist
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520742
4.
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Oncologist
; 29(2): e266-e274, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715957
5.
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.
Oncologist
; 29(1): 75-83, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548439
6.
The emerging role of PI3K inhibitors for solid tumour treatment and beyond.
Br J Cancer
; 128(12): 2150-2162, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36914722
7.
The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046.
Invest New Drugs
; 40(5): 1133-1136, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35612671
8.
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden.
Oncologist
; 25(9): 803-809, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369650
9.
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).
Cancer
; 122(4): 574-81, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26540314
10.
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting.
Cancers (Basel)
; 16(2)2024 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254772
11.
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer.
Cancer Treat Rev
; 128: 102761, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772169
12.
A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing data.
Eur J Cancer
; 190: 112958, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451181
13.
Variant allele frequency: a decision-making tool in precision oncology?
Trends Cancer
; 9(12): 1058-1068, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37704501
14.
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience.
Eur J Cancer
; 183: 79-89, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36801623
15.
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077813
16.
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions.
Expert Rev Clin Pharmacol
; 14(10): 1233-1252, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34591728
17.
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials.
Cancers (Basel)
; 13(22)2021 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830983
18.
The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors.
Eur J Cancer
; 150: 155-167, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33901794
19.
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
J Immunother Cancer
; 9(4)2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849927
20.
Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity.
Eur J Cancer
; 141: 218-224, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33186857